Company profile
IQVIA HOLDINGS INC.
NYSE:IQVBiotechnology: Commercial Physical & Biological Resarch
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04025307 | phase1 | terminated | 2019-08-05 | 2020-12-29 | IQVIA Pty Ltd | Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours |
FDA applications (0)
No records yet.